We are live on ! Find out more
TRHC

Tabula Rasa HealthCare, Inc. Common Stock
TRHC

Delisted

TRHC was delisted on the 2nd of November, 2023.

Back to rankings

1 hedge funds and large institutions have $11 invested in Tabula Rasa HealthCare, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 82 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 84 → 1 (-83)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $168M → $11 (-$168M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 82

Holders
1
Holders Change
-83
Holders Change %
-98.81%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
82
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
ICM
Indaba Capital Management
California
-$67.2M
2
GCL
Glazer Capital LLC
New York
-$10.8M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$9.27M
4
BCM
Beryl Capital Management
California
-$6.1M
5
BlackRock
BlackRock
New York
-$3.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
HNB
1
Huntington National Bank
Ohio
$11 – – –
ICM
2
Indaba Capital Management
California
– -$67.2M -6,521,578 Closed
GCL
3
Glazer Capital LLC
New York
– -$10.8M -1,051,347 Closed
Vanguard Group
4
Vanguard Group
Pennsylvania
– -$9.27M -899,510 Closed
BCM
5
Beryl Capital Management
California
– -$6.1M -591,748 Closed
BlackRock
6
BlackRock
New York
– -$3.83M -371,388 Closed
Qube Research & Technologies (QRT)
7
Qube Research & Technologies (QRT)
United Kingdom
– -$3.8M -368,220 Closed
GF
8
Gabelli Funds
New York
– -$3.67M -355,661 Closed
KCM
9
Kennedy Capital Management
Missouri
– -$3.1M -300,851 Closed
WIC
10
Water Island Capital
New York
– -$2.77M -269,001 Closed
JP Morgan Chase
11
JP Morgan Chase
New York
– -$2.59M -251,613 Closed
GCIA
12
Gabelli & Co Investment Advisers
New York
– -$2.54M -246,250 Closed
Geode Capital Management
13
Geode Capital Management
Massachusetts
– -$2.5M -242,088 Closed
Two Sigma Advisers
14
Two Sigma Advisers
New York
– -$2.49M -241,600 Closed
Two Sigma Investments
15
Two Sigma Investments
New York
– -$2.44M -236,667 Closed
EFI
16
EHP Funds Inc
Canada
– -$2.32M -225,000 Closed
Barclays
17
Barclays
United Kingdom
– -$2.32M -224,778 Closed
CM
18
Crystalline Management
Canada
– -$2.31M -223,850 Closed
PCMI
19
Paradigm Capital Management Inc
New York
– -$2.2M -213,800 Closed
Millennium Management
20
Millennium Management
New York
– -$2.09M -202,388 Closed
Renaissance Technologies
21
Renaissance Technologies
New York
– -$1.58M -153,000 Closed
Goldman Sachs
22
Goldman Sachs
New York
– -$1.53M -148,348 Closed
CM
23
Capula Management
Cayman Islands
– -$1.4M -135,382 Closed
SC
24
Sagefield Capital
Texas
– -$1.33M -129,360 Closed
Marshall Wace
25
Marshall Wace
United Kingdom
– -$1.3M -126,133 Closed
1
2 3 4

TRHC Hedge Fund Activity: Q4 2023 in Review

1 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Tabula Rasa HealthCare, Inc. Common Stock (TRHC) for Q4 2023, worth a combined $11 — down 100% from $168M a quarter earlier.

Sellers outnumbered buyers: 82 funds closed out of TRHC and 0 opened new positions — a net loss of 82 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Indaba Capital Management, exiting entirely with an estimated $67.2M sold.

  • 1 institutional investor held Tabula Rasa HealthCare, Inc. Common Stock (TRHC) as of Q4 2023, down from 84 in Q3 2023.
  • Funds reported $11 of Tabula Rasa HealthCare, Inc. Common Stock stock for Q4 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Tabula Rasa HealthCare, Inc. Common Stock positions in Q4 2023 and 82 closed out, a net change of -82 holders.
  • The largest Tabula Rasa HealthCare, Inc. Common Stock seller in Q4 2023 was Indaba Capital Management, an estimated $67.2M sold.

Based on aggregated 13F filings for Q4 2023.